| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 29 |
| 1 | ASPIRIN 325 MG | 29 |
| 2 | ASPIRIN 81 MG | 29 |
| 3 | DIAZEPAM | 23 |
| 4 | DIAZEPAM ORAL | 22 |
| 5 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 22 |
| 6 | PANTOPRAZOLE | 22 |
| 7 | ETANERCEPT | 20 |
| 8 | DICLOFENAC SODIUM | 19 |
| 9 | MIRTAZAPINE | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFOTETAN DISODIUM | 1 | 0.0089 |
| 1 | CEFOTETAN | 1 | 0.0075 |
| 2 | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0047 |
| 3 | FUTIBATINIB | 1 | 0.0045 |
| 4 | TRIMIPRAMINE | 4 | 0.0036 |
| 5 | CLOMIPRAMINE HYDROCHLORIDE | 13 | 0.0028 |
| 6 | TRIMIPRAMINE MALEATE | 1 | 0.0025 |
| 7 | EFINACONAZOLE | 4 | 0.0020 |
| 8 | L-LYSINE | 1 | 0.0014 |
| 9 | VINORELBINE | 9 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 40 |
| 1 | Benzodiazepine [EPC] | 30 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 29 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 28 |
| 4 | Corticosteroid [EPC] | 21 |
| 5 | Proton Pump Inhibitor [EPC] | 20 |
| 6 | Kinase Inhibitor [EPC] | 19 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 16 |
| 8 | Aromatase Inhibitor [EPC] | 15 |
| 9 | Microtubule Inhibitor [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 11 | 0.0003 |
| 1 | Cephalosporin Antibacterial [EPC] | 2 | 0.0002 |
| 2 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 5 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 6 | Standardized Insect Venom Allergenic Extract [EPC] | 1 | 0.0001 |
| 7 | Aromatase Inhibitor [EPC] | 15 | 0.0001 |
| 8 | Antidote [EPC] | 7 | 0.0001 |
| 9 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |